Patent ID: 9182398
Filing Date: 2015-11-10
Classification: C12Q,G01N

Abstract:
1. A method of quantifying a macrocyclic tricothecene mycotoxin in a patient tissue or a body fluid, the method comprising the steps of: extracting a recovering the tricothecene mycotoxin from the patient tissue or the body fluid wherein the body fluid is selected from the group consisting of a urine sample, a nasal secretion sample, a nasal wash sample, and sputum sample and wherein the patient has been exposed to mold; contacting the tricothecene mycotoxin with an antibody directed against the tricothecene mycotoxin to quantify the tricothecene mycotoxin, wherein the antibody detects macrocyclic tricothecenes; and quantifying the tricothecene mycotoxin to determine whether the patient has a fungal infection that produces macrocuclic tricothecenes wherein the sensitivity of the quantitation is 0.2 ng/ml.